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Background: Myxofibrosarcoma (MFS) arises most commonly in the
proximal extremities of the elderly, where it may involve subcutaneous
and dermal tissues and masquerade as benign entities in limited biopsy
samples. We encountered such a case, in which positivity for CD34 and
morphologic features were initially wrongly interpreted as a
‘low-fat/fat-free’ spindle cell/pleomorphic lipoma. Case series have not
assessed prevalence of CD34 reactivity among cutaneous examples of
MFS.
Methods: We performed a systematic review of our institution’s
experience, selecting from among unequivocal MFS resection
specimens those superficial cases in which a limited biopsy sample
might prove difficult to interpret. These cases were immunostained for
CD34 and tabulated for clinicopathologic characteristics.
Results: After review of all MFS diagnoses over 5 years (n= 56), we
identified a study group of superficial MFS for comparison to the index
case (total n= 8). Of these, the index and three additional cases (4 of 8,
50%; 2 low, 2 high grade) demonstrated positive staining for CD34,
with diffuse staining of spindled cells including cellular processes. Four
additional cases showed no or equivocal/rare staining.
Conclusions: CD34 positivity should be recognized as prevalent
among such cases and should not be inappropriately construed as
inveighing against a diagnosis of MFS in favor of benign entities.
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Myxofibrosarcoma (MFS) represents a tumor
comprised of malignant spindle cells in a myxoid
stroma. The entity was originally considered a
myxoid variant of malignant fibrous histiocytoma.1,2
As currently classified, MFS constitutes a distinctive
entity with reproducible histomorphologic and
clinical features.2 Most distinguishing for MFS, low
grade-cases are characterized histopathologically by
low cellularity, predominantly myxoid stroma and
malignant fibroblastic cells demonstrating spindle
cell morphology and cellular condensation around
characteristic curvilinear blood vessels.3 High-
grade cases are typically more cellular and show
large, pleomorphic atypical cells with abundant
mitoses and necrosis and are essentially pleomorphic
undifferentiated sarcomas with a myxoid stroma.
Individual cases often show a continuum of
microscopic grade. Clinically, MFS tends to occur
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as masses in the proximal limb girdles of elderly
patients where they may involve skeletal muscle,
fascia, subcutaneous adipose and through their
propensity for infiltrative growth, the dermis.4 The
difficulty of rendering a diagnosis in superficially
sampled lesions has been recognized in scattered
case reports5–8 and small series.9,10 We recently
encountered just such a case, in which a superficial,
low-grade component of a MFS was sampled by a
superficial cutaneous biopsy. Immunoreactivity for
CD34, along with other features, initially prompted
an incorrect diagnosis of ‘fat-free/low-fat’ spindle
cell/pleomorphic lipoma.11,12
The case concerned an incisional biopsy from
the right upper posterior arm of an 85-year-old
man, with requisition listing ‘five year history of
lipoma’. The impression of the patient’s primary
care provider was of a ‘benign cyst’, though a
plastic surgery consultation described an indurated
but mobile nodule, suggestive of lipoma arising in
the subcutaneous tissue and pressing against the
dermis. Grossly, the specimen was an unoriented
skin ellipse, 3.0 cm× 1.0 cm. Sections demonstrated
a predominantly well circumscribed lesion with
myxoid stroma and mostly bland admixed spindle
cells. Scattered foci of adipocytes were present
and entrapped ‘ropey collagen’ was prominent,
with scattered mast cells; a ‘low-fat/fat-free’ spindle
cell/pleomorphic lipomawas suspected clinically and
pathologically (Fig. 1A,B). A CD34 immunostain
was ordered and demonstrated diffuse positivity
among spindle cells within the lesion, highlighting its
silhouette at low power (Fig. 1C,D), consistent with
a spindle cell/pleomorphic lipoma.11–14 However,
close inspection identified curvilinear vessels with
perivascular condensation of hyperchromatic spindle
cells (Fig. 1E). On the basis of these worrisome
findings, re-excision was recommended. Sections of
the re-excision showed a deeper seated MFS with
greater cellularity and atypia (Fig. 1F), extending to
within 0.1 cm of the deep margin.
On the basis of this experience, awareness of
the expanding spectrum of CD34-positive cutaneous
entities,15,16 and relative lack of published data on the
prevalence of CD34 immunoreactivity among MFS
in large,1–3,17 recent4,18,19 and cutaneous series, we
undertook a review of our institutional experience
with MFS. Cases with superficial involvement were
selected for study and stained with CD34, with
the intention of better characterizing this potential
diagnostic pitfall.
Materials and methods
After encountering the index case described below
during routine diagnostic practice, we undertook a
systematic review of our institutional experience with
MFS. With approval of the University of Michigan
Institutional Review Board, departmental records
were searched for all cases with diagnosis of MFS
from 2005–2010, resulting in identification of 56
candidate MFS corresponding to 44 patients (10
patients had≥ 2 specimens evaluated). These cases
were deidentified, reviewed to confirm diagnosis,
and canvassed to identify cases where the MFS had
arisen at, or extended to involve, dermis or superficial
subcutaneous tissues (total n= 8). The University of
Michigan employs the grading system developed
by the Fe´de´ration nationale des Centres de lutte
contre le cancer (FNCLCC) for soft tissue sarcoma
grading,20 which is binarized for clinician use into low
grade (FNCLCC Grade 1) or high grade (FNCLCC
Grades 2 and 3) before formal diagnostic reporting.
Herein, for ease of general understanding, each case
was reviewed and the FNCLCC grade reported in
Table 1. Appropriate sectionswere selected forCD34
immunohistochemical staining in the University
of Michigan Clinical Immunohistochemistry Core.
The antibody used was Clone QBEnd10 (Dako,
Carpenteria, CA, USA) at 1/100 dilution for 32min
after preatreatment with CC1 buffer (Dako) for
30min at 95◦C, performed on a Benchmark Ultra
autostainer (Ventana, Tucson, AZ, USA). Staining
was evaluated by consensus by three pathologists
(S.S., A.P., R.P.). For photomicrographs, the slides
were scanned on a ScanscopeXTwhole slide scanner
and photographed in ImageScope (both Aperio,
Vista, CA, USA), at indicated magnifications.
Results
Review of 56 cases from 2005 to 2010 confirmed
the diagnosis in all cases and identified, among
unequivocal resection specimens, 7 additional cases
with superficial extension where a limited biopsy
sample may have presented a similar diagnostic
conundrum to the index case. Importantly, these
cases presented clinicopathologic characteristics con-
sistent with reported MFS cohorts1,3,4,18 including
age range (52–88 years), 4:3 male : female ratio and
wide anatomic distribution (see Table 1). In 5 of 7
cases, benign disease was specifically favored in the
relevant pre-procedural clinician notes; in no case
was MFS suspected prior to pathologic diagnosis.
CD34 staining was unequivocally positive in three
additional cases (Fig. 2A–J). Case 2 concerned a
lesion on the left forearm of a 52-year-old male,
clinically thought to be ‘benign’; this low grade
MFS dissected along tissue planes in the superficial
subcutis, with similar architectural and cytologic
features to that of the index case (Fig. 2A). On
higher power, diagnostic hyperchromatic, atypical
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Fig. 1. Index case of CD34 positive myxofibrosarcoma masquerading as ‘fat-free/low-fat’ spindle cell/pleomorphic lipoma. A) Low-power
micrograph demonstrating a bland spindle cell proliferation with myxoid stroma involving the dermis (×20). B) High power micrograph
showing a focus of mature adipose and ropey collagen (*), with intervening scattered mast cells (arrows) (×400). C) Low-power micrograph
of CD34 immunostain (×200). D) High power micrograph showing unequivocally positive CD34 in cytoplasm and cellular processes of
spindled cells (×400). E) Representative focus from deeper in the lesion, showing distinct curvilinear vessels with perivascular condensation
of hyperchromatic stromal spindle cells (×10). F) Representative micrograph showing a focus of greater cellularity and atypia from the final
resection specimen from the case; definitive necrosis was not identified (×400).
spindle cells can be appreciated (Fig. 2B). CD34
was diffusely positive throughout the lesion, with
individual spindle cells showing varying degrees of
expression of CD34 (Fig. 2C). Case 5 was an excision
of a lesion clinically suspected to be a traumatically
herniated muscle in the left lower leg of an 84-year-
old male. Similar to Case 2, lower power sections of
the lesion demonstrated a more cellular spindle cell
myxoid lesion, dissecting through the subcutaneous
connective tissue and extending superficially toward
the dermis at excision margin (Fig. 2D). On higher
power, mitotic activity was prominent, including
atypical mitoses, signaling a Grade 2 lesion (Fig. 2E).
CD34 was unequivocally positive among the atypical
cells of these lesions (Fig. 2F). Case 6 was an excision
from the left torso of a 65-year-old male, on exam
considered suspicious for a dermatofibrosarcoma
protuberans (Fig. 2G–J). This case demonstrated
areas of classic, low grade, infiltrative MFS as well as
a nodule of higher grade, more cellular morphology
(Fig. 2G–H). Areas within the lesion showed diffuse
positivity for CD34 ranging from a light ‘blush’ with
interspersed more intensely staining pleomorphic
cells (Fig. 2I) to areas of diffuse moderate to intense
stain (Fig. 2J).
Four additional cases showed negative staining
(Fig. 3A–L) for CD34, encompassing a number
of clinical presentations and grades. Of particular
note was Case 3, a low grade MFS that was
diagnosed entirely incidentally in the soft tissue of
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Table 1. Characteristics of study cases
Case Sex Age Site Clinical diagnosis Diagnosis Overall grade* CD34 stain Months Outcome
1, Index M 85 R. upper arm Lipoma MFS FNCLCC Grade 1 +, Spindled cells 15 NED
2 M 52 L. forearm ‘Benign’ MFS FNCLCC Grade 1 +, Subset of
spindled and
atypical cells
81 2 Recurrences (39
months, low
grade; 43 months,
high grade
pleiomorphic)
currently NED
3 M 53 R. thenar Incidental finding, on
carpal Tunnel
surgery
MFS FNCLCC Grade 1 (−), Vessels only 15 NED then LTF
4 F 88 R. forearm ‘Growth’ MFS FNCLCC Grade 2 (−), Rare positive
cellular
processes
17 NED
5 M 84 L. lower leg ‘Herniated muscle’ MFS FNCLCC Grade 2 +, Spindled and
pleomorphic
cells
3 Positive margins,
follow-up
elsewhere
6 M 65 L. torso Dermatofibrosarcoma
protuberans
MFS FNCLCC Grade 2 +, Pleomorphic
cells and
diffuse spindle
cell blush
2 NED then LTF
7 F 82 Central back Lipoma MFS FNCLCC Grade 2 (−), Vessels only 71 NED
8 F 70 L. shin Amelanotic
melanoma
MFS FNCLCC Grade 2 (−), Vessels only 2 NED
NED, no evidence of disease; LTF, lost to follow-up; MFS, myxofibrosarcoma.
*Fe´de´ration nationale des Centres de lutte contre le cancer system grade, as reported.18
the right thenar eminence of a 53-year-old male,
on carpal tunnel surgery (Fig. 3A–C). One case,
Case 4, a ‘growth’ on the right forearm of an 88-
year-old female, showed a number of foci where
wispy cellular processes stained positive for CD34,
though both the lower power appearance and our
overall assessment were that it was negative for
CD34. Case 8, a left shin lesion from a 70-year-old
female considered clinically suspicious for amelanotic
melanoma, showed prominent invasion of the dermis
by MFS spindle cells (Fig. 3J–K), highlighting that
these lesions may extend very superficially, even
nearing the epidermis.
Discussion
The observation of convincing CD34 positive
staining among half of the representative cases of
MFS with superficial involvement described herein
emphasizes the high index of suspicion needed
to make this diagnosis, especially when evaluating
limited biopsy material. The differential diagnosis
of a spindle cell and myxoid superficial lesion is
broad, including, but not limited to, myxoid benign
fibrous histiocytoma, cutaneous myxoma, superficial
acral fibromyxoma, myxoid nerve sheath neoplasms,
myxoid dermatofibrosarcoma protuberans, spindle
cell/pleomorphic lipoma, myxoid solitary fibrous
tumor, myxoinflammatory fibroblastic sarcoma, and
MFS. Moreover, a number of reports have described
cases where low grade MFS has been mistaken
for a number of benign and low-grade malignant
entities, ranging from papular mucinosis7,21 to
myxoid neurofibroma22 to cutaneous myxoma6;
even pleomorphic hyalinizing angioectatic tumor
(PHAT) has been considered.5,8
The potential to interpret a CD34 positive
MFS as a low grade cutaneous neoplasm stems
in part from the fact that an ever expanding
number of cutaneous lesions have been reported to
show frequent immunohistochemical expression of
CD34.15 In particular, Billings et al. and Sachdeva
et al. highlighted this diagnostic difficulty in a series of
‘fat-free/low-fat’ spindle cell/pleomorphic lipomas,
respectively, which are generally CD34 positive.11,12
The overlapping CD34 positivity is important,
especially given the spindle cell/pleomorphic lipoma-
like features of the index case: the ‘ropey
collagen’ proved to be disrupted dermal collagen.
Moreover, the mast cells observed are also a
non-specific feature often encountered whenever
there are myxoid or mucinous changes within the
dermis. Beyond pleomorphic/spindle cell lipoma and
related lesions (mammary-type myofibroblastoma),
the morphologic differential for several of the
cases presented herein would have included
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Fig. 2. Additional CD34-positive myxofibrosarcoma cases. CD34 was overall positive in Case 2 (low grade, A–C), Case 5 (high grade,
D–F) and Case 6 (high grade, G–J) (A,D,G). Representative low-power micrographs for each lesion in first panels; arrows indicate lesions
(×10–×20) (B,E,H). Representative intermediate power micrographs of lesions, arrows indicate mitoses (×200) (C,F,I–J).
myxoinflammatory fibroblastic sarcoma, superficial
acral fibromyxoma, and atypical neurofibroma with
myxoid stroma. All of these entitiesmay show varying
CD34 immunoreactivity.15
In contrast, in the workup ofMFS, CD34 is neither
salient nor generally considered to be of diagnostic
value; it was a distraction from the appropriate
diagnosis in the index case described herein. Of note,
older reports, unselected for anatomical depth of
the lesions, report positivity for the CD34 varying
from approximately 14% in so-called MFH in
general23 to as much as 38% in myxoid MFH.24
Thus, CD34 positivity in MFS is not unprecedented,
with scattered prior reports having identified CD34
expression in MFS from several anatomic sites,25
including skin in some9,26 but not other6,7 scattered
case reports. We interpret the findings from our small
cohort to be cautionary given the number of CD34
positive benign lesions in the differential diagnosis
and the often bland appearance of superficially
sampled MFS.
The caveats of these findings are several.
Principally, the overall frequency of CD34 in MFS,
especially in MFS of deep soft tissues, remains
untested in large contemporary cohorts and should
not be extrapolated from these superficial cases.
Certainly, to make a stronger argument, we would
have preferred to report a greater number of cases,
though we do note that our cohort is a sequential
set of superficial MFS cases from our referral center.
In any case, we intended to study a representative
sample of cases illustrative of a potential diagnostic
pitfall rather than perform an extensive assessment of
MFS CD34 immunophenotype. Finally, we cannot
exclude that a significant subset of the CD34 positive
cells within these lesions may represent entrapped or
reactive dermal fibroblasts; either way, this feature
represents part of the potential diagnostic pitfall.
More important, then, are the lessons from
these cases, especially from our experience of the
index case. The feature in the biopsy that led
to identification of the scattered, hyperchromatic
spindled cells and diagnosis of low grade MFS,
despite the puzzling CD34 stain, was the presence of
several foci of the distinctive curvilinear vasculature
of MFS (Fig. 1E). Classically, in low grade
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Fig. 3. Additional CD34-negative myxofibrosarcoma cases. CD34 was overall negative in Case 3 (low-grade, A–C), Case 4 (high grade, D–F),
Case 7 (high grade, G–I) and Case 8 (high grade, J–L) (A,D,G,J). Representative low-power micrographs for each lesion in the first panels;
arrows indicate lesions (×10–×20) (B,E,H,K). Representative intermediate power micrographs of the lesions (×200) (C,G,I,L). Representative
high power micrographs showing CD34 immunostain for each case; arrows indicate microvasculature, internal positive control (×400).
MFS, these vessels are elongate and arcuate,
traversing a hypocellularmyxoidmatrix and showing
perivascular condensation of spindled and or
inflammatory cells. In the index case, these features
were unequivocally present focally, particularly in
the anatomically deeper areas of the sections, though
the myxoid stromal change was more extensive. This
pervasive stromal change, broadly involving lateral
and deep margins, heralded the finding of a deeper,
more extensive lesion on re-excision and illustrates
the infiltrative growth of these tumors.4,26
Cautionary too are the clinical impressions from
the time of diagnosis, with benign processes favored
in the majority of cases and two cases (carpal
tunnel and muscle herniation surgery) presenting
essentially an incidental diagnosis of sarcoma. The
lack of clinical suspicion before diagnostic biopsies
meant operationally that imaging was not available
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for review at the time of diagnosis in any of these
cases. However, we note that, if available, MRI may
provide very helpful clues to the infiltrative growth
of these lesions27 and may be referenced or even
recommended in difficult cases.
As always with soft tissue lesions, integrating as
much clinical data as possible, from history to
imaging to gross examination, aids in establishing
the correct diagnosis. Essential in our experience
is careful consideration of a broad differential and
review of microscopic sections of deeper levels, with
at least a modicum of suspicion for more serious
lesions, even when they are not suspected clinically.
Based on our findings in these cases, awareness of the
limits and pitfalls of popular adjunctive immunostains
is invaluable.
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